Back to Search Start Over

[Burkitt lymphoma is a highly malign tumour with a doubling time of twenty-four hours].

Authors :
Frølund UC
Nielsen SL
Hansen PB
Source :
Ugeskrift for laeger [Ugeskr Laeger] 2011 Oct 24; Vol. 173 (43), pp. 2714-8.
Publication Year :
2011

Abstract

The treatment results for patients with Burkitt lymphoma have improved markedly over the past 20 years. Focus on the rapid doubling time of the lymphoma, and the frequent involvement of the central nervous system, have led to effective intensive chemotherapy regimens, where several of the drugs cross the blood-brain barrier. The overall survival is now 65-80% even when patients have advanced disease at the time of diagnosis. However, the condition and its complications such as tumour lysis syndrome are acute life threatening, and a quick diagnosis and proper management of complications are essential for the prognosis.

Details

Language :
Danish
ISSN :
1603-6824
Volume :
173
Issue :
43
Database :
MEDLINE
Journal :
Ugeskrift for laeger
Publication Type :
Academic Journal
Accession number :
22027227